Group 1 - The company hosted a specific research meeting with five institutions including Industrial Securities and CITIC Construction Investment on September 11 [1] - The meeting included a tour of the company's exhibition hall and an introduction to its basic situation, followed by in-depth discussions focusing on several business points [2] Group 2 - Iodine and its derivatives are important raw materials in medical, agricultural, industrial, and nutritional fields, with key applications in X-ray contrast agents, disinfectants, etc. According to SQM's 2024 report, these applications account for approximately 63% of global iodine consumption [2] - The company produces inorganic iodides such as potassium iodide and potassium iodate, which are used in pharmaceuticals and pesticides, while its organic iodide product trimethyl iodide is primarily used in the pharmaceutical sector [2] - The company has not yet achieved sales in the solid-state battery sector but plans to explore new industrial application scenarios and conduct feasibility studies [2] - The expansion into hexamethyldisilazane is driven by existing pharmaceutical customer needs and the company's advantages in resource utilization and process technology [2]

Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Co. [1] - The company specializes in iodine and iodine derivatives, which are essential raw materials in various fields including medicine, agriculture, and industry [2][4]. Group 2: Iodine Market Insights - Iodine and its derivatives are widely used in X-ray contrast agents, disinfectants, and LCD screen polarizers, with the three core applications accounting for approximately 63% of global consumption [2][3]. - Major iodine production is concentrated in Chile, Japan, and the United States, which together account for 88% of global sales, with Chilean companies alone contributing about 60% [2][3]. Group 3: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, primarily used in pharmaceuticals, pesticides, and optical materials [4]. - The company also produces trimethyl iodide silane, used as a functional group protecting agent in organic synthesis, particularly in antibiotic production [4]. Group 4: Competitive Advantages - **Circular Development and Comprehensive Service**: The company integrates resource recycling with its main business, ensuring stable supply and low costs through waste material recovery [5]. - **Research and Development Strength**: The company has a professional R&D team with over 30 years of industry experience and has obtained 51 patents as of June 30, 2025 [5]. - **Industry Position**: The company maintains a leading market position in iodides and luminescent materials, with products recognized for their quality and performance [5][6]. - **Quality Control and Customer Relationships**: A comprehensive quality control system ensures high-quality products, fostering long-term partnerships with well-known clients [6]. - **Compliance and Safety**: The company adheres to strict compliance standards, holding all necessary safety and environmental permits, which enhances customer trust [6]. Group 5: Industry Standards and Influence - The company has participated in the formulation of 3 industry standards and 12 group standards, reflecting its influence and technical authority in the industry [6].

Group 1: Market Overview - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, and LCD/LED screens [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, accounting for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of global sales, with Chilean companies alone contributing 60% [2][3] Group 2: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydrogen iodide, and cuprous iodide, primarily used in pharmaceuticals, pesticides, and optoelectronic materials [4] - The organic iodide product trimethyl iodide is utilized as a protecting agent in pharmaceutical synthesis, particularly in the production of antibiotics [4] Group 3: Competitive Advantages - The company integrates resource recycling with core business, creating a circular economy model that ensures stable supply and low costs [5] - A strong R&D team with over 30 years of industry experience has led to the acquisition of 51 patents, enhancing the company’s technological capabilities [5] - The company maintains a leading market position in iodides and luminescent materials, with established long-term partnerships with renowned clients [5][6] Group 4: Quality and Compliance - A comprehensive quality control system spans procurement, production, and sales, ensuring high-quality products and stable supply [6] - The company adheres to compliance in operations, holding all necessary safety and environmental permits, which fosters customer trust and supports sustainable growth [6]

Core Viewpoint - The announcement by Boyuan Co. highlights the significance of iodine and its derivatives as essential raw materials across various sectors, including healthcare, agriculture, and industry, with a focus on their applications in key products [1] Industry Overview - Iodine is widely used in various formulations as a key component or catalyst, with applications in X-ray contrast agents, disinfectants, pharmaceutical intermediates, LCD and LED screen polarizers, chemicals, organic compounds, and pigments [1] - Iodine is added to table salt in the form of potassium iodate or potassium iodide to prevent iodine deficiency [1] Market Structure - According to SQM's 2024 report, the downstream application structure of iodine is dominated by three core sectors: X-ray contrast agents, pharmaceutical manufacturing, and liquid crystal panel manufacturing, which together account for approximately 63% of global consumption [1] - The global iodine industry exhibits a distinct regional distribution, with major production concentrated in Chile, Japan, and the United States, which collectively account for 88% of global sales [1] - Five companies in Chile account for about 60% of global iodine sales, with SQM alone representing approximately 37% of this total; eight Japanese producers contribute around 23%, while U.S. producers account for nearly 5% [1] - Additional production exists in Russia, Turkmenistan, Azerbaijan, Indonesia, and China, albeit in smaller quantities [1]